Drop in biological initiation for patients with psoriasis during the COVID-pandemic.

Like Comment
Biologics have become the backbone of chronic inflammatory diseases treatment, including psoriasis. Post-approval studies allowed to better understand their safety profile demonstrating a favorable risk-benefit ratio despite an increased risk of infection, and especially an increased risk of bacterial infection with anti-TNF agents.

View the full article @ The British journal of dermatology

Get PDF with LibKey
Authors: L Penso, R Dray-Spira, A Weill, M Zureik, E Sbidian


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6577 Contributions
0 Following